Discovery of Clinical Candidate GSK1842799 As a Selective S1P1 Receptor Agonist (Prodrug) for Multiple Sclerosis. - Deng H; Bernier SG; Doyle E; Lorusso J; Morgan BA; Westlin WF; Evindar G (ACS medicinal chemistry letters, 2013)